Cosopt PF is administered for the purpose of treating eye and open-angle glaucoma in patients who respond negatively to other drugs. Cosopt PF drops contain a beta-blocker and carbonic anhydrase inhibitor combination. The drug works by decreasing the production of fluid and pressure in the human eye. Cosopt PF is a combination of two drugs (timolol maleate and dorzolamide hydrochloride). Dorzolamide belongs to carbonic anhydrase inhibitors class of drugs while timolol belongs to Beta-blockers.
Cosopt PF is a combination of drugs used in the treatment of high pressure inside a person’s eye caused by glaucoma and other eye conditions. Such conditions affecting the eye can damage the optic nerve. If these conditions are not treated, they can result in the permanent blindness of the eye.
Cosopt PF is importantly used to prevent as well as treat the increased pressure inside an eye or eyes also referred to as ocular hypertension as well as glaucoma mainly the open angle type in patients having difficulties responding to other forms of medication.
Cosopt PF comes in the form of drops and contains a combination of beta-blocker, and an inhibitor referred to as Carbonic anhydrase that normally helps to bring down or lower the fluid amount within the eye. Lowering or decreasing pressure and production of excess fluid inside the eye will help prevent other serious conditions such as blindness. It is important for patients using this drug to seek doctors’ advice before using it to get the proper information on how to use it.